Sharon Hesterlee

2.0k total citations
10 papers, 291 citations indexed

About

Sharon Hesterlee is a scholar working on Molecular Biology, Genetics and Pharmacology. According to data from OpenAlex, Sharon Hesterlee has authored 10 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Genetics and 3 papers in Pharmacology. Recurrent topics in Sharon Hesterlee's work include Muscle Physiology and Disorders (5 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Pharmaceutical industry and healthcare (3 papers). Sharon Hesterlee is often cited by papers focused on Muscle Physiology and Disorders (5 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Pharmaceutical industry and healthcare (3 papers). Sharon Hesterlee collaborates with scholars based in United States, Germany and Canada. Sharon Hesterlee's co-authors include Matthew Harker, Bray Patrick‐Lake, Jamie Roberts, Eric L. Eisenstein, Bennett Levitan, Kenneth Getz, Joseph A. DiMasi, Michelle P. Goldberg, Sophia K. Smith and Wendy Selig and has published in prestigious journals such as PLoS ONE, Muscle & Nerve and Orphanet Journal of Rare Diseases.

In The Last Decade

Sharon Hesterlee

9 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon Hesterlee United States 7 115 84 74 58 44 10 291
Randi E. Zinberg United States 13 52 0.5× 32 0.4× 76 1.0× 196 3.4× 23 0.5× 24 467
Melissa Ross United States 11 75 0.7× 59 0.7× 31 0.4× 41 0.7× 6 0.1× 34 330
Colin Halverson United States 14 95 0.8× 59 0.7× 46 0.6× 333 5.7× 12 0.3× 39 666
Myra I. Roche United States 18 116 1.0× 39 0.5× 94 1.3× 252 4.3× 9 0.2× 41 890
Lorenzo Guizzaro Netherlands 8 22 0.2× 118 1.4× 29 0.4× 35 0.6× 8 0.2× 21 289
Sabrina A. Suckiel United States 13 43 0.4× 36 0.4× 92 1.2× 142 2.4× 9 0.2× 23 467
Miranda L. G. Hallquist United States 10 54 0.5× 41 0.5× 30 0.4× 83 1.4× 5 0.1× 14 311
James O’Leary United States 9 55 0.5× 18 0.2× 38 0.5× 84 1.4× 6 0.1× 13 274
Hui Yuan China 11 24 0.2× 11 0.1× 73 1.0× 41 0.7× 6 0.1× 42 363
Mauro Zucchetto United Kingdom 9 39 0.3× 15 0.2× 26 0.4× 14 0.2× 7 0.2× 10 274

Countries citing papers authored by Sharon Hesterlee

Since Specialization
Citations

This map shows the geographic impact of Sharon Hesterlee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Hesterlee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Hesterlee more than expected).

Fields of papers citing papers by Sharon Hesterlee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Hesterlee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Hesterlee. The network helps show where Sharon Hesterlee may publish in the future.

Co-authorship network of co-authors of Sharon Hesterlee

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Hesterlee. A scholar is included among the top collaborators of Sharon Hesterlee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Hesterlee. Sharon Hesterlee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Lek, Angela, Evrim Atas, Brian L. Lin, et al.. (2024). Meeting Report: 2023 Muscular Dystrophy Association Summit on ‘Safety and Challenges in Gene Therapy of Neuromuscular Diseases’. Journal of Neuromuscular Diseases. 11(5). 1139–1160. 1 indexed citations
2.
Lek, Angela, Evrim Atas, Sharon Hesterlee, Barry J. Byrne, & Carsten G. Bönnemann. (2023). Meeting Report: 2022 Muscular Dystrophy Association Summit on ‘Safety and Challenges in Gene Transfer Therapy’. Journal of Neuromuscular Diseases. 10(3). 327–336. 23 indexed citations
3.
Lek, Angela, et al.. (2023). The Muscular Dystrophy Association’s neuroMuscular ObserVational Research Data Hub (MOVR): Design, Methods, and Initial Observations. Journal of Neuromuscular Diseases. 10(3). 365–380. 2 indexed citations
4.
Peay, Holly L., Ryan Fischer, Janice Tzeng, et al.. (2019). Gene therapy as a potential therapeutic option for Duchenne muscular dystrophy: A qualitative preference study of patients and parents. PLoS ONE. 14(5). e0213649–e0213649. 29 indexed citations
5.
Levitan, Bennett, Kenneth Getz, Eric L. Eisenstein, et al.. (2017). Assessing the Financial Value of Patient Engagement: A Quantitative Approach from CTTI’s Patient Groups and Clinical Trials Project. Therapeutic Innovation & Regulatory Science. 52(2). 220–229. 94 indexed citations
6.
Bloom, Diane, Matthew Harker, Sharon Hesterlee, et al.. (2017). The Rules of Engagement: CTTI Recommendations for Successful Collaborations Between Sponsors and Patient Groups Around Clinical Trials. Therapeutic Innovation & Regulatory Science. 52(2). 206–213. 36 indexed citations
7.
Hesterlee, Sharon, Shashi Amur, Lisa J. Bain, et al.. (2017). Patient-Centered Therapy Development for Myotonic Dystrophy: Report of the Myotonic Dystrophy Foundation–Sponsored Workshop. Therapeutic Innovation & Regulatory Science. 51(4). 516–522. 2 indexed citations
8.
Heslop, Emma, Cristina Csimma, Volker Straub, et al.. (2015). The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development. Orphanet Journal of Rare Diseases. 10(1). 49–49. 16 indexed citations
9.
Smith, Sophia K., Wendy Selig, Matthew Harker, et al.. (2015). Patient Engagement Practices in Clinical Research among Patient Groups, Industry, and Academia in the United States: A Survey. PLoS ONE. 10(10). e0140232–e0140232. 60 indexed citations
10.
Mendell, Jerry R., Cristina Csimma, Craig M. McDonald, et al.. (2006). Challenges in drug development for muscle disease: A stakeholders' meeting. Muscle & Nerve. 35(1). 8–16. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Randi E. Zinberg Breakdown of academic impact, for papers by Melissa Ross Breakdown of academic impact, for papers by Colin Halverson Breakdown of academic impact, for papers by Myra I. Roche Breakdown of academic impact, for papers by Lorenzo Guizzaro Breakdown of academic impact, for papers by Sabrina A. Suckiel Breakdown of academic impact, for papers by Miranda L. G. Hallquist Breakdown of academic impact, for papers by James O’Leary Breakdown of academic impact, for papers by Hui Yuan Breakdown of academic impact, for papers by Mauro Zucchetto
Rankless by CCL
2026